MAXIMUS, Inc. Announces Quarterly Dividend of $0.28 (NYSE:MMS)

MAXIMUS, Inc. (NYSE:MMS) announced a quarterly dividend on Wednesday, January 8th, Zacks reports. Stockholders of record on Friday, February 14th will be given a dividend of 0.28 per share by the health services provider on Friday, February 28th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date of this dividend is Thursday, February 13th.

MAXIMUS has increased its dividend payment by an average of 0.8% per year over the last three years and has raised its dividend every year for the last 1 years. MAXIMUS has a payout ratio of 30.1% meaning its dividend is sufficiently covered by earnings. Analysts expect MAXIMUS to earn $4.14 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 27.1%.

Shares of NYSE MMS opened at $73.91 on Thursday. The company has a market capitalization of $4.75 billion, a P/E ratio of 19.87, a P/E/G ratio of 1.85 and a beta of 0.79. MAXIMUS has a 12 month low of $67.98 and a 12 month high of $82.02. The stock has a 50 day moving average of $74.40 and a 200-day moving average of $75.39.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings results on Tuesday, November 19th. The health services provider reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.01). MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. The business had revenue of $754.97 million for the quarter, compared to analyst estimates of $756.40 million. During the same period in the prior year, the business earned $0.71 EPS. The company’s revenue for the quarter was up 35.2% compared to the same quarter last year. On average, equities analysts predict that MAXIMUS will post 4.02 EPS for the current fiscal year.

Several analysts recently commented on MMS shares. ValuEngine raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a report on Friday, October 25th. Zacks Investment Research raised shares of MAXIMUS from a “sell” rating to a “hold” rating and set a $83.00 price target on the stock in a report on Monday, December 23rd. Finally, Wells Fargo & Co cut their price objective on shares of MAXIMUS from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Wednesday.

In related news, Vice Chairman Richard A. Montoni sold 11,028 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $73.33, for a total value of $808,683.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas D. Romeo sold 6,758 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $75.71, for a total value of $511,648.18. Following the completion of the sale, the insider now owns 8,340 shares of the company’s stock, valued at $631,421.40. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,375 shares of company stock valued at $2,250,533. 2.20% of the stock is currently owned by insiders.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Read More: What is an Initial Coin Offering (ICO)?

Dividend History for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit